ArticleClinical drug investigation2025

Authors' Reply to Noguchi et al. Comment on: "Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors Used in Patients with Diabetes and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database".

Toshiaki Sakamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.